AstraZeneca’s CRISPR collaborations aim to identify drug targetsAstraZeneca has announced four research collaborations that will use CRISPR, a pioneering genome-editing technique, to identify and validate potential drug targets.…
Drug shortages: it’s time for Europe to act Unlike the United States, Europe has no plan for coordinated action to mitigate drug shortages.…
Almost 42% of US drinkers report taking drugs that interact with alcohol Some 41.5% of US adults who drink alcohol report taking medicines known to interact with alcohol, according to research published in Alcoholism: Clinical and Experimental Research.…
Treating mental health disorders in children and adolescents ‘Clinical handbook of psychotropic drugs for children and adolescents 3rd edition’ by Elbe D, Bezchlibnyk-Butler K Z, Virani A S , Procyshyn R M.…
Gold standard guidance on injectable drugs ‘Handbook on injectable drugs, 18th edition’, editor-in-chief Gerald K McEvoy.…
Paclitaxel plus trastuzumab tested in node-negative HER2-positive breast cancer Researchers report promising results for paclitaxel plus trastuzumab in some patients with node-negative HER2-positive breast cancer.…
More UK patients will now be eligible for two costly hepatitis C treatments Sofosbuvir has received the green light from NICE but will not be available to patients until August 2015, while simeprevir will only be accessible through a patient access scheme.…
Direct-to-consumer genetic tests should come with a health warning Genetic testing is appropriate in certain situations, but for healthy people as a way to predict disease, it is imprecise and comes with a number of risks.…
A complete reference guide to vaccine production ‘Vaccine Development and Manufacturing’, edited by Emily P Wen, Ronald Ellis, Narahari S Pujar.…
Shire announces US$5.2bn acquisition of NPS PharmaceuticalsShire has announced a US$5.2bn acquisition of the US company NPS Pharmaceuticals following unanimous approval by both company boards.…